The Role of Oxaliplatin-Based Versus Cisplatin-Based Regimens in Advanced Gastric Cancer: A Systematic Review and Pooled Analysis of the Chinese Literature

2010 ◽  
Vol 6 (3) ◽  
pp. 214-221
Author(s):  
Fenghua Wang ◽  
Fanggong Jiang ◽  
Yuhong Li ◽  
Ying Guo ◽  
Lin Shen ◽  
...  
2015 ◽  
Vol 16 (8) ◽  
pp. 1148-1159 ◽  
Author(s):  
Domenico Ciliberto ◽  
Nicoletta Staropoli ◽  
Francesca Caglioti ◽  
Simona Gualtieri ◽  
Lucia Fiorillo ◽  
...  

2001 ◽  
Vol 37 ◽  
pp. S229
Author(s):  
J.C. Lee ◽  
S.R. Park ◽  
S.H. Lee ◽  
M.W. Sung ◽  
D.S. Heo ◽  
...  

2017 ◽  
Vol 94 (11) ◽  
pp. 812-820
Author(s):  
Evgeniya S. Fedoseeva ◽  
M. V. Savostikova ◽  
M. N. Narimanov ◽  
A. A. Pashaev ◽  
S. S. Kirichenko ◽  
...  

This review is designed to discuss possibilities for the treatment of advanced gastric cancer with reference to the prognostic and predictive value of molecular-biological parameters and the influence of hereditary predisposition to the development of neoplastic process. The data on modern pharmacotherapy of this disease based on the knowledge of molecular-biological parameters are presented including the following markers: HER2/neu, VGFR, c-met, TUBB3, CDH-1, BRCA-1, EGFR, TGF-ß, p53, Ki67 and PCNA. It is emphasized that the role of molecular-biological parameters associated with advanced gastric cancer is ambiguous. The prognostic and predictive significance of some of the markers is confirmed while that of others remains to be elucidated and requires further research.


2013 ◽  
Vol 24 (10) ◽  
pp. 2581-2588 ◽  
Author(s):  
L. Stenholm ◽  
J. Stoehlmacher-Williams ◽  
S.E. Al-Batran ◽  
N. Heussen ◽  
S. Akin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document